Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients with HIV in the United States

By sjmartinez • May 6, 2025

Nambiar P, Liang T, Labo N, Hand J, Blumberg EA, Rana MM, Florman S, Haydel B, Morris MI, Schaenman J, Rodrigues MMS, Werbel WA, Bowring MG, Friedman-Moraco RJ, Stock P, Stosor V, Mehta S, Gilbert AJ, Elias N, Mehta SA, Small CB, Haidar G, Malinis M, Pereira MR, Aslam S, Wojciechowski D, La Hoz R, Santos CAQ, Apewokin S, Castillo-Lugo JA, Ranganna K, Morsheimer M, Massie A, Segev DL, Miley W, Marshall V, Whitby D, Tobian AAA, Durand CM. Kaposi Sarcoma-Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients with HIV in the United States. Clin Infect Dis. 2025 May 5:ciaf229. doi: 10.1093/cid/ciaf229. Epub ahead of print. PMID: 40324947.

Tags: HHV8 seroprevalence, HIV, HOPE Act, Human Herpesvirus 8, Infectious Diseases, Kaposi sarcoma, KSHV seroprevalence, Organ transplantation, Publications

Related Posts

Uptake of the COVID-19 vaccine and its association with vaccine information and misinformation in Malawi

Songo J, Whitehead HS, Phiri K, Kalande P, Lungu E, Phiri S, van Oosterhout J, Moses A, Hoffman RM, Moucheraud C. Uptake of the COVID-19[...]

Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study

Maertens JA, Thompson GR 3rd, Spec A, Donovan FM, Hammond SP, Bruns AHW, Rahav G, Shoham S, Johnson R, Rijnders B, Schaenman J, Hoenigl M,[...]

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment

Munroe ES, Grandits GA, Hyzy RC, Prescott HC, Barrett TW, Dewar RL, Engen N, Goodman AL, Hatlen TJ, Highbarger H, Holland TL, Hughes G, Jensen[...]